Figure 2From: Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients Overall survival (OAS) and disease-free survival (DFS) for TNBC (n = 844) versus non-TNBC (n = 8.312) and for TNBC versus the groups defined by HR status and Her2 status (adjusted for year of diagnosis, tumor size, grading, nodal status, menopausal status, and comorbidity). Back to article page